Michael Chin details the recent news that The Damon Runyon Cancer Research Foundation has named four exceptional researchers as beneficiaries of the prestigious Damon Runyon-Sohn Pediatric Cancer Research Fellowship Award, submitting about $1 million to address a basic lack of subsidizing for pediatric disease research.

1. $ 1 MILLION BOOST TO PEDIA TRIC
CA NCER RESEA RCH
Everything You Need To Know About the New
B Y M I C H A E L C H I N

2. A NEW GROUP OF
LEA DERS
Pediatric cancer research just scored a big win. In July, four
young pediatric cancer researchers were awarded $ 1 million in
fellowship money to pursue innovative treatments for an area
of cancer that' s largely underfunded.

3. DEFINING THE NEED
Since cancer happens less much of the time in youngsters and
teens than in grown- ups, pediatric cancer research does not get
noteworthy financing from either the National Cancer Institute
or the biopharmaceutical business.
Of course, this then means that are fewer advances and fewer
researchers in this field.

4. BUT SOME INSTITUTIONS
A RE STEPPING IN TO
CHA NGE THINGS

5. The Damon Runyon Cancer Research Foundation and Sohn
Conference Foundations combined efforts to award four
outstanding young scientists as recipients of the prestigious
Damon Runyon- Sohn Pediatric Cancer Research Fellowship,
The fellows represent some of the best and brightest minds in
the medical field who will take an intrepid approach to tackling
cancers in children and young adults.

6. MEET THE FELLOWS
Challice L. Bonifant, MD, PhD
1
2
3
3
4
Dr. Bonifant will study how best to direct the immune system to
combat acute myeloid leukemia ( AML) , a blood cancer of both children
and adult. The goal: Develop new strategies to treat AML.
Michael A. Koldobskiy, MD, PhD
Dr. Koldobskiy will study the ways that cancer cells rely on chemical
marks that modify the expression of genes. The goal: Identify new
targets for treatment of pediatric acute lymphoblastic leukemia,
Tamara P. Miller, MD
Dr. Miller will study the toxicities of cancer treatment and improving
how the side effects of leukemia treatment are reported. The goal:
Define the true rates of toxicities of leukemia therapy
Cara A. Rabik, MD, PhD
Dr. Rabik will study how mutations in the WT1 gene result in
methylation changes in acute myeloid leukemia. The goal: Evaluate if
certain drugs can efficiently treat this particular mutation.

7. With the hard work and insight of these
four doctors--and many others--we'll
continue making strides in this
particularly underserved area of
research.

8. michaelchinworcester.org
@MichaelChin_
A
PRESENTA TION
BY
MICHA EL CHIN
Source: DAMON RUNYON CANCER
RESEARCH FOUNDATION. "Four
Young Pediatric Cancer Research
Fellows Earn $1 Million in New
Awards."EurekAlert!, 21 July 2016. Web.
18 Aug. 2016.